•
Mar 31, 2014

Jazz Pharmaceuticals Q1 2014 Earnings Report

Total Revenue
$247M
Previous year: $196M
+25.8%
EPS
$1.61
Previous year: $1.37
+17.5%
Gross Profit
$216M
Previous year: $169M
+27.8%
Cash and Equivalents
$246M
Previous year: $451M
-45.4%
Total Assets
$3.2B
Previous year: $2.01B
+59.1%

Jazz Pharmaceuticals

Jazz Pharmaceuticals